Assembly Biosciences (ASMB) Capital Expenditures Growth (1y) (2013 - 2024)
Assembly Biosciences (ASMB) Capital Expenditures Growth (1y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 143.40% |
| 10 | Assembly Biosciences | 444.73 Mn | 218.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 102.51% |
| Dec 31, 2023 | 16.92% |
| Sep 30, 2023 | 335.88% |
| Jun 30, 2023 | -3.15% |
| Dec 31, 2022 | -5,188.89% |
| Sep 30, 2022 | -94.97% |
| Jun 30, 2022 | -1,015.25% |
| Mar 31, 2022 | 231.84% |
| Sep 30, 2021 | 300.42% |
| Jun 30, 2021 | -97.29% |
| Mar 31, 2021 | -1,456.52% |
| Sep 30, 2020 | -152.76% |
| Jun 30, 2020 | 6,706.25% |
| Mar 31, 2020 | 98.64% |
| Dec 31, 2019 | -92.89% |
| Sep 30, 2019 | 8,532.43% |
| Jun 30, 2019 | -65.22% |
| Dec 31, 2018 | -41.69% |
| Sep 30, 2018 | -92.65% |
| Dec 31, 2017 | 1,479.87% |